The IPO Buzz: Required Reading
Two of this week’s nine IPOs have attracted some investors’ interest. One company is a spinoff providing a platform to streamline cloud software development and the other is developing next-generation cancer therapies to boost patients’ immune systems. All you need to know can be found in their prospectuses. For that matter, if you read the prospectus for each of the rest of this week’s IP..
Read more April 15, 2018IPO Calendar
| Company | Symbol proposed | Shares (Millions) | Est. $ Volume | Expected to Trade | SCOOP Rating | Rating Change |
|---|---|---|---|---|---|---|
| Alzheon | ALZH | 5.0 | $ 70.0 mil | 4/16/2018 Day-to-Day | S/O | S/O |
| GrafTech International Ltd. | EAF | 35.0 | $ 525.0 mil | 4/19/2018 Priced | S/O | S/O |
| Mereo BioPharma Group plc | MREO | 2.8 | $ 49.9 mil | 4/19/2018 Day-to-Day | S/O | S/O |
Last 100 IPOs - April 18, 2018
| Number of IPOs priced : | 100 |
| Number Up: | 58 |
| Number Down: | 42 |
| Number Unchanged: | 0 |
| Percentage Change From Issue Price: | 18.62% |
| Percentage Change for The Nasdaq Composite | 12.78% |
2018 IPO Scorecard - April 18, 2018
| Number of IPOs priced (Excluding 12 units) : | 45 |
| Number Up: | 20 |
| Number Down: | 25 |
| Number Unchanged: | 0 |
| Total Return From Issue Price: | 6.67% |
| The Nasdaq Composite Index YTD % Change | 5.47% |